Dr. Chhablani recently shared #OCU410 Phase 1/2 data with @RetinalPhys. Phase 1 results show 23% slower GA lesion growth over 12 months and Phase 2 interim 6-month results show 27% slower GA lesion growth-- a key benefit over the approved drugs for GA.
🔗https://t.co/83o4GOjD1O
$OCGN
#mRNA Vs #COVAXIN
Read the real-world data Vs the one they made up. Then ask yourself why are cases in the USA going up again? Why is India distancing itself from Biden regime? Why did Fauci and the NIH withhold raw material from India during a crucial point to bring #COVAXIN to Americans?
I have all the answers after digging for 3 years but you won't like what I found. I have the receipt saved so lmk if you want them.
I want a safer option for our youth because they at our future!
#CourageousInnovation
#RetinitisPigmentosa
#LeberCongenitalAmaurosis
#GeneTherapy #CellTherapy #COVAXIN #OCU500
Proud to announce positive Phase 2/3 data for our injectable COVID-19 vaccine candidate. The successful completion of this study brings us one step closer to providing an additional vaccine option, which remains critical to the management of COVID-19. https://t.co/tydOnhi4dA
@CDCgov Have you no shame? You lied to a company and blocked a truly life saving traditional vaccine in favor of corporate greed. You will be held accountable. #COVAXIN
@akheriaty@MarioNawfal In addition, the @US_FDA delayed traditional(non mRNA) alternatives like #Covaxin, an inactivated whole virion vaccine
https://t.co/ZgPmVFt2Oq
@POTUS Help us get traditional(non mRNA) vaccine #Covaxin for a broad, more durable protection OR the new intranasal vaccine that helps slow transmission!
#WashU
https://t.co/5P2hU967Kt